Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial
Titel:
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial
Auteur:
Paz-Ares, Luis Goto, Yasushi Wan-Teck Lim, Darren Halmos, Balazs Chul Cho, Byoung Cobo, Manuel Luis González Larriba, José Zhou, Caicun Demedts, Ingel Atmaca, Akin Baka, Sofia Mookerjee, Bijoyesh Portella, Socorro Zhu, Zewen Wu, Jincheng Demanse, David Dharan, Bharani Reck, Martin